Omar W S, Eissa S, Moustafa H, Farag H, Ezzat I, Abdel-Dayem H M
Department of Radiation Oncology, Cairo University Egypt.
Anticancer Res. 1997 May-Jun;17(3B):1639-44.
The aim of this project was to study the kinetics of both Tl and Tc-99m MIBI in PBM by evaluating tumor to normal tissue ratio in early (E) images acquired within 1/2 hour and delayed (D) images acquired three hours following the i.v. injection of 3 mCi (111 MBq) of Tl and 20 mCi (740 MBq) of MIBI on 2 separate days in 49 patients. The washout index was calculated from E ratio minus D ratio divided by E ratio. A negative ratio indicating build up of activity in D images and a positive ratio indicated washout of activity from the E images. In addition, the findings were correlated with the following immunohistochemical parameters: pathological grading, number of cells in mitotic division (PCNA- Ki-67), angiogenesis (well formed and ill formed blood vessels) and presence or absence of Bcl 2 Oncogene (release antiapoptotic signals). Results showed that in all benign and malignant lesions, MIBI showed consistent washout varying from 19-27% while with Tl, there was persistent washout in all benign lesions and mixed washout or buildup varying from +16% to minus 17% in malignant lesions, (E) ratios showed a reasonable correlation between Tl and MIBI (r = 0.5). There was more significant correlation between the D ratios (r = 0.8). Due to high (E) MIBI uptake ratios and their higher percentage of washout than Tl, delayed ratios came close to each other. Immunohistochemical analysis revealed benign lesions presented with low mitotic rate: Ki-67 (71.4%), PCNA (14.2%), low amount of ill formed blood vessels (42.8%) and high amount well formed blood vessels (100%). While malignant lesions presented with high mitotic rate Ki-67 was (96.7%), PCNA (100%), high amount of ill formed blood vessels (73.3% in GII and 100% in Grade III) and less amount of well formed blood vessels of 90% and 83.4% in Grade II and III respectively. Bcl-2 was variable in both benign and malignant lesions with 71.4% in benign, 73.4% in GII and 16.7 in GIII malignancy. In conclusion, early uptake ratio in both benign and malignant tumors is related to the degree of angiogenesis, percentage of ill formed blood vessels, high mitotic activity reflected by high grade of tumor and high percentage of PCNA and Ki-67.
本项目的目的是通过评估在49例患者中于静脉注射3毫居里(111兆贝可)铊和20毫居里(740兆贝可)甲氧基异丁基异腈后的不同日期,在半小时内采集的早期(E)图像和三小时后采集的延迟(D)图像中的肿瘤与正常组织比值,来研究铊和锝-99m甲氧基异丁基异腈在原发性乳腺病(PBM)中的动力学。洗脱指数通过(E比值减去D比值)除以E比值来计算。负比值表明在D图像中活性增加,正比值表明从E图像中活性洗脱。此外,研究结果与以下免疫组化参数相关:病理分级、有丝分裂细胞数量(增殖细胞核抗原- Ki-67)、血管生成(良好形成和不良形成的血管)以及Bcl-2癌基因的存在与否(释放抗凋亡信号)。结果显示,在所有良性和恶性病变中,甲氧基异丁基异腈显示出一致的洗脱,洗脱率在19%至27%之间,而对于铊,所有良性病变中均有持续洗脱,恶性病变中则有混合洗脱或增加,范围从 +16% 至 -17%,(E)比值显示铊和甲氧基异丁基异腈之间存在合理的相关性(r = 0.5)。D比值之间的相关性更显著(r = 0.8)。由于甲氧基异丁基异腈的(E)摄取比值较高且其洗脱百分比高于铊,延迟比值彼此接近。免疫组化分析显示,良性病变的有丝分裂率较低:Ki-67为(71.4%),增殖细胞核抗原为(14.2%),不良形成血管数量较少(42.8%),良好形成血管数量较多(100%)。而恶性病变的有丝分裂率较高,Ki-67为(96.7%),增殖细胞核抗原为(100%),不良形成血管数量较多(II级为73.3%,III级为100%),II级和III级中良好形成血管数量分别为90%和83.4%。Bcl-2在良性和恶性病变中均有变化,良性病变中为71.4%,II级恶性病变中为73.4%,III级恶性病变中为16.7%。总之,良性和恶性肿瘤的早期摄取比值与血管生成程度、不良形成血管百分比、由高肿瘤分级反映的高有丝分裂活性以及增殖细胞核抗原和Ki-67的高百分比有关。